Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

Rhox2e Inhibitors

Rhox2e inhibitors are a class of chemical compounds that specifically target and inhibit the activity of Rhox2e, a transcription factor within the Rhox (Reproductive Homeobox) gene family. Rhox2e is involved in regulating the expression of genes crucial for development, cellular differentiation, and reproductive processes. As a transcription factor, Rhox2e contains a homeobox DNA-binding domain that enables it to interact with specific regulatory sequences in the genome, modulating the transcription of target genes. These genes often control key biological pathways related to cell growth, maintenance, and tissue development. Inhibitors of Rhox2e typically act by binding to the protein's functional regions, such as its DNA-binding domain or regions essential for protein-protein interactions. This prevents Rhox2e from carrying out its role in gene regulation, thereby disrupting its ability to influence the expression of its target genes.

The inhibition of Rhox2e results in altered transcriptional activity in the biological processes it normally regulates, particularly those involved in reproduction and development. By blocking Rhox2e's function, these inhibitors interfere with the gene expression programs responsible for proper cellular differentiation and tissue-specific development, leading to a disruption of normal biological processes. Rhox2e inhibitors are valuable tools for researchers aiming to study the precise role of this transcription factor in broader gene regulatory networks, as they allow for a detailed examination of how Rhox2e contributes to the control of development and reproductive functions. Additionally, these inhibitors provide insights into the functional relationships within the Rhox family, helping scientists understand how different Rhox genes collaborate or act independently in gene regulation. Furthermore, Rhox2e inhibitors offer a way to investigate the evolutionary conservation of homeobox genes, shedding light on how transcription factors like Rhox2e have evolved to regulate critical biological processes in various species, particularly in the context of development and reproduction.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$128.00
$505.00
2
(1)

A DNA methyltransferase inhibitor that could indirectly affect RHOX2E expression by altering methylation patterns.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

A histone deacetylase inhibitor that may enhance RHOX2E expression by increasing histone acetylation, leading to a more open chromatin structure.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

A DNA demethylating agent that could potentially increase RHOX2E expression by reducing methylation levels at its promoter.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

A ROCK inhibitor that might indirectly influence RHOX2E activity by altering cytoskeletal organization and cellular signaling.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

An MEK inhibitor that could indirectly affect RHOX2E function by modulating MAPK/ERK signaling pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor that might impact RHOX2E activity by affecting AKT signaling and transcription factor activity.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$80.00
$212.00
$408.00
48
(1)

Inhibits TGF-β signaling which could indirectly influence RHOX2E expression or activity.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

A JNK inhibitor potentially affecting transcription factors and genes associated with RHOX2E activity.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

A histone deacetylase inhibitor, like TSA, could potentially increase RHOX2E expression.